Your browser doesn't support javascript.
loading
Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing.
Malla, RamaRao; Viswanathan, Sathiyapriya; Makena, Sree; Kapoor, Shruti; Verma, Deepak; Raju, Alluri Ashok; Dunna, Manikantha; Muniraj, Nethaji.
Afiliación
  • Malla R; Cancer Biology Laboratory, Department of Biochemistry and Bioinformatics, GITAM School of Science, GITAM (Deemed to be University), Visakhapatnam 530045, Andhra Pradesh, India.
  • Viswanathan S; Department of Biochemistry, ACS Medical College and Hospital, Chennai 600007, Tamil Nadu, India.
  • Makena S; Maharajah's Institute of Medical Sciences and Hospital, Vizianagaram 535217, Andhra Pradesh, India.
  • Kapoor S; Department of Genetics, University of Alabama, Birmingham, AL 35233, USA.
  • Verma D; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
  • Raju AA; Medicover Hospitals, Visakhapatnam 530022, Andhra Pradesh, India.
  • Dunna M; Center for Biotechnology, Jawaharlal Nehru Technological University, Hyderabad 500085, Telangana, India.
  • Muniraj N; Center for Cancer and Immunology Research, Children's National Hospital, 111, Michigan Ave NW, Washington, DC 20010, USA.
Cancers (Basel) ; 16(8)2024 Apr 11.
Article en En | MEDLINE | ID: mdl-38672545
ABSTRACT
Cancer persists as a global challenge necessitating continual innovation in treatment strategies. Despite significant advancements in comprehending the disease, cancer remains a leading cause of mortality worldwide, exerting substantial economic burdens on healthcare systems and societies. The emergence of drug resistance further complicates therapeutic efficacy, underscoring the urgent need for alternative approaches. Drug repurposing, characterized by the utilization of existing drugs for novel clinical applications, emerges as a promising avenue for addressing these challenges. Repurposed drugs, comprising FDA-approved (in other disease indications), generic, off-patent, and failed medications, offer distinct advantages including established safety profiles, cost-effectiveness, and expedited development timelines compared to novel drug discovery processes. Various methodologies, such as knowledge-based analyses, drug-centric strategies, and computational approaches, play pivotal roles in identifying potential candidates for repurposing. However, despite the promise of repurposed drugs, drug repositioning confronts formidable obstacles. Patenting issues, financial constraints associated with conducting extensive clinical trials, and the necessity for combination therapies to overcome the limitations of monotherapy pose significant challenges. This review provides an in-depth exploration of drug repurposing, covering a diverse array of approaches including experimental, re-engineering protein, nanotechnology, and computational methods. Each of these avenues presents distinct opportunities and obstacles in the pursuit of identifying novel clinical uses for established drugs. By examining the multifaceted landscape of drug repurposing, this review aims to offer comprehensive insights into its potential to transform cancer therapeutics.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2024 Tipo del documento: Article País de afiliación: India Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2024 Tipo del documento: Article País de afiliación: India Pais de publicación: Suiza